Source:
Medical education online [Med Educ Online] 2024 Dec 31; Vol. 29 (1), pp. 2312716. Date of Electronic Publication: 2024 Feb 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9806550 Publication Model:
Source:
Medical education online [Med Educ Online] 2024 Dec 31; Vol. 29 (1), pp. 2327818. Date of Electronic Publication: 2024 Mar 13.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9806550 Publication Model:
Source:
Medical education online [Med Educ Online] 2024 Dec 31; Vol. 29 (1), pp. 2336331. Date of Electronic Publication: 2024 Apr 05.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9806550 Publication Model:
Authors : Chen L; Department of Immunization Planning, Luohu District Center for Disease Control and Prevention, Shenzhen, China.; Shenzhen Field Epidemiology Training Program (SZFETP), Shenzhen, China.
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2302220. Date of Electronic Publication: 2024 Jan 12.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2303796. Date of Electronic Publication: 2024 Jan 31.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Authors : Stefanos R; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2308378. Date of Electronic Publication: 2024 Feb 19.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2311476. Date of Electronic Publication: 2024 Feb 14.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Authors : Rincon NL; Trinity College of Arts & Sciences, Duke University, Durham, NC, USA.; REACH Equity Summer Undergraduate Research Program (RESURP), Duke University School of Medicine, Durham, NC, USA.
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2313249. Date of Electronic Publication: 2024 Mar 27.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2323264. Date of Electronic Publication: 2024 Apr 10.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2325745. Date of Electronic Publication: 2024 Apr 02.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Authors : O'Bryan SE; Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, USA.; Muñoz F
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2326781. Date of Electronic Publication: 2024 Mar 18.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication
Source:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2327145. Date of Electronic Publication: 2024 Mar 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication